Systemic considerations in bilateral central retinal vein occlusion

Optometry

Volumn 78, Issue 8, 2007, Pages 402-408

  Tomasini, Dawn N ^a   Segu, Bhagya ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antiphospholipid antibody syndrome; Central retinal vein occlusion; Dysproteinemias; Hyperhomocysteinemia; Systemic lupus erythematosus

Indexed keywords

ADULT; ANEMIA; ARTICLE; CASE REPORT; DEPRESSION; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; RETINA VEIN OCCLUSION; RISK FACTOR;

ADULT; ANEMIA; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 34447641083     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2006.12.017     Document Type: Article

References (19)

1. Lahey J.M., Tunc M., Kearney J., et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 109 1 (2002) 126-131
2. Lahey J.M., Kearney J.J., and Tunc M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 9 5 (2003) 385-392
3. Prisco D., and Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 32 5-6 (2002) 308-311
4. Cooney M.J., Fekrat S., and Finkelstein D. Current concepts in the management of central retinal vein occlusion. Curr Opin Ophthalmol 9 3 (1998) 47-50
5. Arevalo J.F., Lowder C.Y., and Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 13 6 (2002) 404-410
6. Wong N.N. Systemic lupus erythematosus. In: Thomann K.H., Marks E.S., and Adamcyzk D.T. (Eds). Primary eyecare in systemic disease. 2nd ed. (2001), McGraw Hill, New York 291-301
7. Mills J.A. Systemic lupus erythematosus. N Engl J Med 330 26 (1994) 1871-1879
8. Myers H. Dysproteinemias. In: Thomann K.H., Marks E.S., and Adamcyzk D.T. (Eds). Primary eyecare in systemic disease. 1st ed. (1995), Appleton & Lange, Norwalk 526-532
9. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 10 (2002) 752-763
10. Song Y.H., Kim C.G., Kim S.D., et al. Systemic lupus erythematosus presenting earlier as retinal vaso-occlusion. Korean J Intern Med 16 3 (2001) 210-213
11. Sawa M., Saito Y., Kameda C., et al. Ocular complications in systemic lupus erythematosus-choroidal and retinal pigment epithelial changes. Nippon Ganka Gakkai Zasshi 106 8 (2002) 474-480
12. Bolling J.P., and Brown G.C. The antiphospholipid antibody syndrome. Curr Opin Ophthalmol 11 (2000) 211-213
13. Glacet-Bernard A., Bayani N., Chretien P., et al. Antiphospholipid antibodies in retinal vascular occlusions. Arch Ophthalmol 112 (1994) 790-795
14. Stadtmauer E.A. Multiple myeloma, 2004-one or two transplants?. N Engl J Med 349 26 (2003) 2551-2553
15. Vine A.K. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. Trans Am Ophthalmol Soc 98 (2000) 493-503
16. Hasset AC. Hyperhomocysteinemia. The Institute for Transfusion Medicine. 2003: Issue 6. Available at: http://www.itxm.org/tmu2003/issue2003-6.htm. Last accessed April 4, 2007.
17. Yildirim C., Yaylali V., Tatlipinar S., et al. Hyperhomocysteinemia: a risk factor for retinal vein occlusion. Ophthalmologica 218 2 (2004) 102-106
18. Brown B.A., Marx J.L., Thomas W.P., et al. Homocysteine: a risk factor for retinal venous occlusive disease. Am Acad Ophthalmol 109 (2002) 287-290
19. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 4 (1997) 486-491